Cryo Cell International INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
AMEX
Cryo-Cell International, Inc. reported a net loss of $2.43 million for fiscal year 2025, a significant decline from the previous year's profit, primarily due to an impairment charge on public inventory and ongoing litigation with Duke University.
AMEX
Cryo-Cell International's 10-K filing reveals a 2% revenue increase for fiscal year 2024, overshadowed by an ongoing arbitration with Duke University and strategic shifts in business operations.
AMEX
Cryo-Cell International, Inc. released its annual 10-K report, outlining its financial performance, strategic initiatives, and risk factors for the fiscal year ended November 30, 2023.